Unity Biotechnology, Inc. (UBX) Social Stream



Unity Biotechnology, Inc. (UBX): $2.44

0.06 (+2.52%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add UBX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#135 of 359

in industry

UNITY BIOTECHNOLOGY INC (UBX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering UBX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-05 6 $12 $4 $7.8 $2.45 218.37%
2021-11-12 6 $12 $4 $7.666 $2.45 212.9%
2021-12-15 7 $12 $4 $7.142 $2.45 191.51%
2022-05-12 7 $12 $4 $7.142 $2.45 191.51%
2022-05-17 5 $12 $3 $6.857 $2.45 179.88%
2022-08-15 6 $12 $3 $6.857 $2.45 179.88%
2022-08-16 6 $12 $3 $7.428 $2.45 203.18%
2022-10-13 6 $120 $30 $78.333 $2.45 3097.27%
2022-10-20 6 $120 $11 $75.166 $2.45 2968%
2022-11-02 6 $120 $11 $74.5 $2.45 2940.82%
2022-11-10 6 $120 $10 $56 $2.45 2185.71%
2022-11-11 6 $80 $10 $38 $2.45 1451.02%
2022-11-16 6 $80 $10 $26.666 $2.45 988.41%
2023-03-20 5 $80 $10 $29.8 $2.45 1116.33%
2023-04-05 5 $12 $5 $7.6 $2.45 210.2%
2023-05-15 5 $12 $3 $7.2 $2.45 193.88%
2023-05-26 5 $12 $3 $7.4 $2.45 202.04%
2023-05-31 6 $12 $3 $7.833 $2.45 219.71%
2023-06-26 6 $10 $2 $6.8 $2.45 177.55%
2023-07-10 6 $12.001 $2 $7.666 $2.45 212.9%
2023-08-11 6 $12 $2 $7.666 $2.45 212.9%
2023-08-31 6 $10 $2 $7.333 $2.45 199.31%

The Trend in the Analyst Price Target


Over the past 41 weeks, UBX's average price target has gone down $22.47.

UBX reports an average of 1,322.53% for its upside potential over the past 46 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-10-13 6 12 3 7.833 0.405 1834.07%
2022-10-13 6 120 30 78.333 0.405 19241.48%
2022-11-10 6 120 10 56.000 2.120 2541.51%
2023-06-26 6 10 2 6.800 3.110 118.65%
2023-08-11 6 12 2 7.666 2.600 194.85%

UBX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 5 0 1 0 0 6

The Trend in the Broker Recommendations


Over the past 42 months, UBX's average broker recommendation rating improved by 0.17.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • UNITY BIOTECHNOLOGY INC's variance in analysts' estimates is lower than -2418.73% of all US stocks.
  • In the context of all US stocks, UNITY BIOTECHNOLOGY INC's upside potential (average analyst target price relative to current price) is higher than 2391.92% of them.
  • UBX has a greater average analyst price target than 546.43% of all US stocks.
  • In terms of how UNITY BIOTECHNOLOGY INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 1908.23% of that group.

Stocks similar to UNITY BIOTECHNOLOGY INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are FIXX, BTAI, and MBIO.

Make investment decisions regarding UBX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!